Heart attack survivors: shorter blood thinner course may be safer and effective
NCT ID NCT07507500
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study involves 8,100 adults who had a heart attack and received a stent. It compares different approved blood-thinning strategies to see which one best prevents another heart attack, stroke, or death while also reducing serious bleeding. Participants will either receive a shorter course of dual therapy followed by one drug, or the standard 12-month dual therapy. The goal is to improve long-term outcomes without increasing risks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYOCARDIAL INFARCTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fundación Jiménez Díaz University Hospital
Madrid, Spain
-
Mater Private Network Dublin
Dublin, Ireland
-
Oslo University Hospital, Ullevål.
Oslo, Norway
-
Paula Stradiņa klīniskā universitates slimnīca
Riga, Latvia
-
Saint John Paul II Hospital in Cracow
Krakow, Poland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which strategy wins for heart attack patients with multiple blocked arteries?
- Can a Plant-Based diet calm the immune system after a heart attack?
- When is the best time to fix other blocked arteries after a heart attack?
- Your smartwatch may predict a heart attack days before it happens
- Can a quick shot stop a heart attack in its tracks?
- A sharper eye on the heart: new blood test aims to spot heart attacks faster